Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2013 Jan 18:14:18.
doi: 10.1186/1471-2369-14-18.

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH

Takahiro Kuragano  1 , Minoru Furuta, Mana Yahiro, Aritoshi Kida, Yoshinaga Otaki, Yukiko Hasuike, Akihide Matsumoto, Takeshi Nakanishi
Affiliations
Controlled Clinical Trial

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH

Takahiro Kuragano et al. BMC Nephrol. .

Abstract

Background: Recently, acetate-free citrate containing dialysate (A(-)D) was developed. We have already reported about the significant effect of A(-)D on metabolic acidosis, anemia, and malnutrition in maintenance hemodialysis (MHD) patients. In this study, we compared the effect of A(-)D and acetate containing dialysate (A(+)D) on serum calcium and intact-parathyroid hormone (int-PTH) levels.

Method: Single session study: Seventeen patients were treated with A(+)D in one session and also treated with A(-)D in another session. Serum levels of pH, HCO3-, total (t)-calcium, ionized (i)-calcium, and int-PTH were evaluated at the beginning and the end of each session. Cross over study: A total of 29 patients with MHD were treated with A(+)D for 4 months, switched to A(-)D for next 4 months, and returned to A(+)D for the final 4 months.

Results: In single session study, serum i-calcium and t-calcium levels significantly increased, and int-PTH levels decreased after HD with A(+)D, whereas HD with A(-)D did not affect iCa and int-PTH. In cross over study, if all patients were analyzed, there was no significant difference in serum int-PTH or bone alkaline phosphatase (BAP) levels during each study period. In contrast, in the patients with low int-PTH (<60 pg/mL), serum levels of int-PTH and BAP were significantly increased during the A(-)D, without significant changes in serum t-calcium or i-calcium levels.

Conclusion: A(-)D containing citrate could affect calcium and PTH levels, and, in 4 month period of crossover study, increased int-PTH levels pararelled with increasing BAP levels, exclusively in MHD patients with low int-PTH levels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in pH and HCO3- after HD with A(−) and A(+)D in a single session.
Figure 2
Figure 2
Changes in i-calcium, t-calcium, and int-PTH levels after HD with A(−)D and A(+)D in a single session.
Figure 3
Figure 3
Changes in HCO3- levels in all patients, patients with HCO3- ≥ 20 mEq/L and patients with HCO3- < 20 mEq/L in the cross-over study. Error bars are standard deviations. *P < 0.05.
Figure 4
Figure 4
Changes in pre-dialysis t-calcium and i-calcium levels in the patients with int-PTH ≥ 180 pg/mL (A), 60–180 pg/mL (B), and int-PTH < 60 pg/mL (C) in the cross-over study.
Figure 5
Figure 5
Changes in pre-dialysis int-PTH and BAP levels in the patients with int-PTH ≥ 180 pg/mL (A), 60–180 pg/mL (B), and int-PTH < 60 pg/mL (C) during the study period. int-PTH: intact parathyroid hormone; BAP: bone-specific alkaline phosphatase. Error bars are standard deviations. *P < 0.05.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kuragano T, Furuta M, Kida A, Kitamura R, Nanami M, Otaki Y, Nonoguchi H, Nakanishi T. A case of a maintenance hemodialysis patient in whom a change of sensitivity to acetate was suspected. ASAIO J. 2010;56(5):488–490. doi: 10.1097/MAT.0b013e3181f11e9d. - DOI - PubMed
    1. Kuragano T, Kida A, Furuta M, Yahiro M, Kitamura R, Otaki Y, Nonoguchi H, Matsumoto A, Nakanishi T. Effects of acetate-free citrate-containing dialysate on metabolic acidosis, anemia, and malnutrition in hemodialysis patients. Artif Organs. 2012;36(3):282–290. doi: 10.1111/j.1525-1594.2011.01349.x. - DOI - PubMed
    1. Malluche HH, Ritz E, Lange HP, Schoeppe W. Changes of bone histology during maintenance hemodialysis at various levels of dialyzate Ca concentration. Clin Nephrol. 1976;6:440–447. - PubMed
    1. Eiselt J, Racek J, Opatrný K Jr. The effect of hemodialysis and acetate-free biofiltration on anemia. Int J Artif Organs. 2000;23:33–40. - PubMed
    1. Drüeke TB, Touam M. Calcium balance in haemodialysis–do not lower the dialysate calcium concentration too much (con part) Nephrol Dial Transplant. 2009;24:2990–2993. doi: 10.1093/ndt/gfp365. - DOI - PubMed

Publication types

LinkOut - more resources